Dopamine in heart failure and critical care

Clinical and Experimental Hypertension

Volumn 22, Issue 3, 2000, Pages 269-276

  Smit, A J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Critical care; Dopamine; Heart failure; Septic shock

Indexed keywords

ANTIARRHYTHMIC AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOPAMINE; IBOPAMINE;

AORTA SURGERY; CONFERENCE PAPER; DRUG EFFECT; DRUG INDICATION; DRUG INDUCED DISEASE; DRUG SAFETY; HEART FAILURE; HUMAN; INTENSIVE CARE; PHARMACOEPIDEMIOLOGY; SEPTIC SHOCK;

CARDIOTONIC AGENTS; CONTROLLED CLINICAL TRIALS; CRITICAL CARE; DEOXYEPINEPHRINE; DOPAMINE; DOPAMINE AGONISTS; FENOLDOPAM; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; TREATMENT OUTCOME;

EID: 0034122488     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.1081/CEH-100100076     Document Type: Conference Paper

References (23)

1. Rajfer S.I., Rosen, J.D., Nemanich, J.W., Douglas, F.L., Davis, F., Osinski, J. Sustained hemodynamic improvement during long-term therapy with levodopa in heart failure: role of plasma catecholamines. J Am Coll Cardiol. 1987; 10: 1286-1293.
2. Nichols, A.J., Smith, J.M. Jr., Shebuski, R.J., Ruffolo, R.R. Jr. Comparison of the effects of the novel inotropic agent, ibopamine, with epinine, dopamine and fenoldopam on renal vascular dopamine receptors in the anesthetized dog. J Pharmacol Exp Ther. 1987; 242: 573-578.
3. Lieverse, A.G., Girbes, A.R.J., VanVeldhuisen, D.J., Smit, A.J., Zijlstra, J.G., Meijer, S., Lie, K.I., Reitsma, W.D.. The effects of ibopamine on glomerular filtration rate and plasma norepinephrine remain preserved during prolonged treatment in patients with congestive heart failure. Eur Heart J. 1995; 16: 937-942 .
4. Van Veldhuisen, D.J., Brouwer, J., Man-in-'t-Veld, A.J., Dunselman, P.H., Boomsma, F., Lie, K.I.. Progression of mild untreated heart failure during six months follow-up and clinical and neurohumoral effects of ibopamine and digoxin as monotherapy. DIMT Study Group. Dutch Ibopamine Multicenter Trial. Am J Cardiol. 1995; 75: 796-800.
5. Rousseau, M.F., Raigoso, J., van Eyll, C., van Mechelen, H., Musso, N.R., Lotti, G., Pouleur H. Effects of intravenous epinine administration om left ventricular systolic performance, coronary hemodynamics, and circualting catecholamines in patients with heart failure. J Cardiovasc Pharmacol. 1992; 19: 155-162.
6. Hampton, J.R., Van Veldhuisen, D.J., Kleber, F.X., Cowley, A.J., Ardia, A., Block, P., Cortina, A., Cserhalmi, L., Follath, F., Jensen, G., Kayanakis, J., Lie, K.I., Mancia, G., Skene, A.M. Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure. Second Prospective Randomised Study of Ibopamine on Mortality and Efficacy (PRIME II). Lancet. 1997; 349: 971-977.
7. Girbes, A.R.J., Zijlstra, J.G. Ibopamine and survival in severe congestive heart failure: PRIME II. Lancet. 1997; 350: 147-148
8. Feenstra, J., in't Veld, B. A., van der Linden, P.D., Grobbee, D.E., Stricker, B.H. Risk factors for mortality in users of ibopamine. Br J Clin Pharmacol. 1998; 46: 71-77.
9. McDonald, T.M., Jeffrey, R.F., Muir, A.L., Lee, M.R. A preliminary study of the dopamine DA1 agonist fenoldopam in the treatment of chronic left ventricular failure due to ischemic heart disease. Eur J Clin Pharmacol 1990; 38: 199-201.
10. Goldberg, L.I. Cardiovascular and renal actions of dopamine: potential clinical applications. Pharmacol Rev. 1972; 183: 256-263.
11. Smit, A.J. Renal effects of exogenous and endogenous dopamine. Thesis, University of Groningen, 1988.
12. Duke, G.J., Bersten, A.D. Dopamine and renal salvage in the critically ill. Anaesth Intens Care. 1992; 20: 277-302.
13. Wee, P.M. ter, Smit, A.J., Rosman, J.B., Sluiter, W.J., Donker, A.J.M. Effect of intravenous infusion of low-dose dopamine on renal function in normal individuals and in patients with renal disease. Am J Nephrol. 1986, 6: 42-46.
14. Smit, A.J., Meijer, S., Wesseling, H., Reitsma, W.D., Donker, A.J.M. Impaired renal hemodynamic but conserved natriuretic response to dopamine in patients with renal disease. Nephron. 1989; 52: 338-346.
15. Orme, M.L.E., Breckenridge, A., Dollery, C.T. The effects of long-term administration of dopamine on renal function in hypertensive patients. Eur j Clin pharmacol. 1973; 6: 150-155.
16. Lherm, T., Troche, G., Rossignol, M., Bordes, P., Zazzo, J.F.. Renal effects of low-dose dopamine in patients with sepsis syndrome or septic shock treated with catecholamines. Intensive Care Med. 1996; 22: 213-219.
17. Girbes, A.R.J., Lieverse, A.G., Smit, A.J., van Veldhuisen, D.J., Zwaveling, J.H., Meijer, S., Reitsma, W.D. Lack of specific renal haemodynamic effects of different doses of dopamine after infrarenal aortic surgery. Br J Anaesth. 1996; 77: 753-757.
18. Hoogenberg, K., Smit, A.J., Girbes, A.R.J. Effects of low-dose dopamine on renal and systemic hemodynamics during incremental norepinephrine infusion in healthy volunteers. Crit Care Med. 1998; 26: 260-265
19. Marik, P.E., Mohedin, M. The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. JAMA. 1994; 272: 1354-1357.
20. Sinclair, D.G., Houldsworth, P.E., Keogh B., Pepper, J., Evans, T.W. Gastrointestinal permeability following cardiopulmonary bypass: a randomised study comparing the effects of dopamine and dopexamine. Intens care Med. 1997; 23; 510-516.
21. Neviere, R., Mathieu, D., Chagnon, J-L., Lebleu, N., Wattel F. The contrasting effects of dobutamine and dopamine on gastric mucosal perfusion in septic patients. Am J Respir Care Med. 1996; 154: 1684-1688.
22. Meier-Hellmann, A., Bredle, D.L., Specht, M., Spies, C., Hannemann, L., Reinhart, K . The effects of low-dose dopamine on splanchnic blood flow and oxygen uptake in patients with septic shock. Intensive Care Med. 1997; 23: 31-37.
23. Van de Borne, P., Oren, R., Somers, V.K. Dopamine depresses minute ventilation in patients with heart failure. Circulation. 1998; 98: 126-131.